Chronic Liver Disease (CLD)
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers
Ultrasound Prediction of Esophageal Variceal Bleeding Risk
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
Heart Problems in Children With Chronic Liver Disease
EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG
Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy
Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function